| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.6M | +0.5% | +65.4% |
| Cost of Revenue | $13.2M | -12.9% | +216.3% |
| Gross Profit | $433K | +127.3% | -89.4% |
| R&D Expense | $3.0M | +6.9% | -31.5% |
| SG&A Expense | $6.0M | +0.0% | -60.5% |
| Operating Income | -$10.6M | +12.1% | +43.3% |
| Pre-tax Income | -$11.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.8M | +1286.7% | +623.4% |
| Accounts Receivable | $6.7M | +23.7% | -34.7% |
| Inventory | $35.4M | -7.9% | -42.9% |
| Current Assets | $59.2M | +21.0% | -25.8% |
| Total Assets | $93.9M | +19.5% | -15.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.6M | — | — |
| Capital Expenditures | $2.1M | — | — |
| Investing Cash Flow | -$2.1M | — | — |
| Financing Cash Flow | $32.3M | — | — |
| Free Cash Flow | -$21.7M | — | — |
| +13.4% |
| +48.2% |
| Income Tax | -$14K | -115.7% | — |
| Net Income | -$11.8M | +14.0% | +48.3% |
| EPS (Basic) | -$0.69 | +29.6% | +72.1% |
| EPS (Diluted) | -$0.69 | +29.6% | +72.1% |
| $37.6M |
| -12.1% |
| -40.7% |
| Long-term Debt | $23.0M | +2.4% | -28.6% |
| Total Liabilities | $63.7M | +11.8% | -16.2% |
| Stockholders' Equity | $30.2M | +40.0% | -13.1% |